MedPath
NMPA Approval

Mobocertinib Succinate Capsules

国药准字HJ20230001

January 10, 2023

Drug Information

琥珀酸莫博赛替尼胶囊

安卫力

胶囊剂

40mg(按C₃₂H₃₉N₇O₄计)

化学药品

January 10, 2023

January 9, 2028

Company Information

Applicant Company

95 Hayden Avenue, Lexington, MA 02421 United States of America

Manufacturing Company

xcelience, llc

5415 West Laurel Street, Tampa, Florida (FL) 33607 USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥珀酸莫博赛替尼胶囊 - NMPA 批准文号 | MedPath